logo logo

医疗器械模板

  • Home
  • |
  • About us
  • |
  • Tianlu News
  • |
  • Products
  • |
  • Quality Assurance
  • |
  • R&D Center
  • |
  • Human Resources
  • |
  • Contact us
English
  • 中文
Tianlu NEWS

CEP re-granted

2025-02-28
Through continuous technological R&D and innovation, in February 2025, our company has once again obtained the Certificate of Suitability to the European Pharmacopoeia (CEP) issued by the European ...

THE ATTACHMENT OF HALAL CERTIFICATE

2024-11-20
In November 2024, Ursodeoxycholic Acid(UDCA) developed by Tianlu Biopharmaceutical successfully obtained HALALCertification from Indonesia. This certification confirms that the productfully complie...

The visit of Science and Technology Bureau

2023-03-14
Technology helps enterprises’ developmentOn March 10, 2023, Li Qi, deputy directorof Wuzhong District Science and Technology Bureau, led a team to visit Suzhou Tianlu and Mr Lu, Suzhou Tianlu's gen...

Safety Production Secondary Standardization Acceptance on October 22, 2020

2020-10-22
From October 22, 2020 to October 23, 2020, an inspection team organized by the Jiangsu Provincial Emergency Management Department conducted a two-day on-site inspection of our company’s safety product

District Mayor Li of Wuzhong District led a team to our company to inspect work safety

2020-10-22
On  the morning of October 22, 2020, Li Chaoyang, Mayor of Wuzhong District, led a team which includes the District Emergency Management Bureau, Eco-Environment Bureau, Fire Rescue Brigade, Developmen
more
Address:1128 Yin Zhong south Road Wuzhong Economic Development Zone,Suzhou Jiangsu China
TEL: 86-512-65657288  Business Sales: 86-512-65657388  FAX: 86-512-65653288
Mail:sales@sz-tlzy.com

©2023 Suzhou Tianlu Bio-pharmaceutical Co.,Ltd.

Powered by:缘震网络苏ICP备17053592号-2